MAKOVSKI, Tatjana T, Jinane GHATTAS, Stephanie MONNIER-BESNARD, Lisa CAVILLOT, Monika AMBROŽOVÁ, Barbora VASINOVA, Rodrigo FETEIRA-SANTOS, Peter BEZZEGH, Felipe Ponce BOLLMANN, James COTTAM, Romana HANEEF, Brecht DEVLEESSCHAUWER, Niko SPEYBROECK, Paulo Jorge NOGUEIRA, Maria Joao FORJAZ, Joel COSTE and Laure CARCAILLON-BENTATA. Multimorbidity and frailty are associated with poorer SARS-CoV-2-related outcomes: systematic review of population-based studies. AGING CLINICAL AND EXPERIMENTAL RESEARCH. NEW YORK: SPRINGER, 2024, vol. 36, No 1, p. 1-30. ISSN 1594-0667. Available from: https://dx.doi.org/10.1007/s40520-023-02685-4.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Multimorbidity and frailty are associated with poorer SARS-CoV-2-related outcomes: systematic review of population-based studies
Authors MAKOVSKI, Tatjana T, Jinane GHATTAS, Stephanie MONNIER-BESNARD, Lisa CAVILLOT, Monika AMBROŽOVÁ (203 Czech Republic, belonging to the institution), Barbora VASINOVA (203 Czech Republic), Rodrigo FETEIRA-SANTOS, Peter BEZZEGH, Felipe Ponce BOLLMANN, James COTTAM, Romana HANEEF, Brecht DEVLEESSCHAUWER, Niko SPEYBROECK, Paulo Jorge NOGUEIRA, Maria Joao FORJAZ, Joel COSTE and Laure CARCAILLON-BENTATA.
Edition AGING CLINICAL AND EXPERIMENTAL RESEARCH, NEW YORK, SPRINGER, 2024, 1594-0667.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30304 Public and environmental health
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.000 in 2022
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s40520-023-02685-4
UT WoS 001161688700002
Keywords in English COVID-19; SARS-CoV-2; Multimorbidity; Multiple chronic conditions; Frailty
Tags 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 10/6/2024 12:18.
Abstract
BackgroundEstimating the risks and impacts of COVID-19 for different health groups at the population level is essential for orienting public health measures. Adopting a population-based approach, we conducted a systematic review to explore: (1) the etiological role of multimorbidity and frailty in developing SARS-CoV-2 infection and COVID-19-related short-term outcomes; and (2) the prognostic role of multimorbidity and frailty in developing short- and long-term outcomes. This review presents the state of the evidence in the early years of the pandemic. It was conducted within the European Union Horizon 2020 program (No: 101018317); Prospero registration: CRD42021249444.MethodsPubMed, Embase, World Health Organisation COVID-19 Global literature on coronavirus disease, and PsycINFO were searched between January 2020 and 7 April 2021 for multimorbidity and 1 February 2022 for frailty. Quantitative peer-reviewed studies published in English with population-representative samples and validated multimorbidity and frailty tools were considered.ResultsOverall, 9,701 records were screened by title/abstract and 267 with full text. Finally, 14 studies were retained for multimorbidity (etiological role, n = 2; prognostic, n = 13) and 5 for frailty (etiological role, n = 2; prognostic, n = 4). Only short-term outcomes, mainly mortality, were identified. An elevated likelihood of poorer outcomes was associated with an increasing number of diseases, a higher Charlson Comorbidity Index, different disease combinations, and an increasing frailty level.DiscussionFuture studies, which include the effects of recent virus variants, repeated exposure and vaccination, will be useful for comparing the possible evolution of the associations observed in the earlier waves.
PrintDisplayed: 15/7/2024 09:27